CRON vs. ATXI

In the year-to-date period, CRON achieves a -1.98% return, which is significantly higher than ATXI's -88.00% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Cronos Group Inc. (CRON) and Avenue Therapeutics, Inc. (ATXI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CRON Sharpe Ratio is -0.71, which is comparable to the ATXI Sharpe Ratio of -0.99. The chart below compares the historical Sharpe Ratios of CRON and ATXI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither CRON nor ATXI has paid dividends to shareholders.

The maximum CRON drawdown since its inception was -93.16%, smaller than the maximum ATXI drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for CRON and ATXI. For additional features, visit the drawdowns tool.

The current volatility for Cronos Group Inc. (CRON) is 12.04%, while Avenue Therapeutics, Inc. (ATXI) has a volatility of 30.84%. This indicates that CRON experiences smaller price fluctuations and is considered to be less risky than ATXI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Cronos Group Inc. and Avenue Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.